Insider sale
TAYSHA GENE THERAPIES, INC.
$158.5K
33.61K shares
What this filing means
MCGINNIS EMILY plans to sell 33.61K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $158.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001977343-26-000005
33.61K
Shares to sell
$158.5K
Approx. market value
901.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
2/3/2026
901.00Total acquired901.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 901.00 | — |
| Total | 901.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.59K
Market value
$35.0K
1/26/2026
—Completed
Units to sell
25.12K
Market value
$119.3K
1/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
901.00
Market value
$4.3K
2/4/2026
Total
Units
33.61K
Value
$158.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 7.59K | $35.0K | — | Completed |
1/23/2026 | 25.12K | $119.3K | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 901.00 | $4.3K | Nasdaq | Planned |
| Total | 33.61K | $158.5K | ||